Reduced Diagnostic Yield of Whole Exome Sequencing in Patients With Chromosomal Microarray Detected Copy Number Variants of Uncertain Significance
Twin Research and Human Genetics · 30.10.2026 · 1-8
DOI: 10.1017/thg.2026.10109 ↗Kurz gefasst
Fachartikel in der Zeitschrift Twin Research and Human Genetics, online erschienen am 30.10.2026. Verfasst von Lily Loughman und 12 weiteren Autor:innen. Beteiligte Einrichtung: Genetic Health Western Australia, Australia. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Chromosomal microarray is a first-line genetic test for many individuals with neurodevelopmental disorders and congenital anomalies. A common outcome is identification of a copy number variant of uncertain significance (CNV VUS), frequently prompting referral to a clinical genetics service. In the setting of a CNV VUS finding, clinical geneticists often proceed to whole exome sequencing (WES) to determine whether an alternative molecular diagnosis is present. The aim of this study was to determine whether the diagnostic yield of WES differs in individuals with a chromosomal microarray-detected CNV VUS compared with those without a reportable CNV, and to use this difference to estimate the proportion of CNV VUS that are likely to be disease-causing. Individuals who underwent WES at Genetic Health Western Australia (January-December 2022) were included. Phenotype and results were collected from retrospective medical record review. Results found that 32/177 (18%) individuals who underwent WES had an abnormal finding on microarray. WES identified causative variants in 27% overall, with a lower diagnostic yield in those with CNV VUS than those without (11% vs. 30%, p = .023). No diagnoses were made on WES for the 13 patients who had CNV VUS duplications ( p = .020), nor for the 16 individuals with CNV VUS 0.6Mb or larger ( p = .006). It was concluded that individuals with a CNV VUS had a significantly lower diagnostic yield from WES, suggesting that many reportable CNV VUS identified by chromosomal microarray are themselves responsible for the presenting phenotype. Based on the observed difference in diagnostic yield, approximately half of CNV VUS may represent the underlying molecular diagnosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Genetic Health Western Australia, Australia.
- University of New South Wales School of Women's and Children's Health, Australia.
- NSW Health, Australia.
- Diagnostic Genomics, PathWest Laboratory Medical WA, Australia.
- The University of Western Australia School of Biomedical Sciences, Australia.
- School of Paediatrics and Child Health, The University of Western Australia Faculty of Health and Medical Sciences, Australia.
ORCID-Profile: Lily Loughman
Zitieren
APA
Loughman, L., Goh, S., Woodward, K. J., Ricciardi, J. L., Wise, C., Poulton, C., Townshend, S., Pathak, G., McKenzie, F., McGinnis, K., Slee, J., Kiraly-Borri, C., & Kamien, B. (2026). Reduced Diagnostic Yield of Whole Exome Sequencing in Patients With Chromosomal Microarray Detected Copy Number Variants of Uncertain Significance. Twin Research and Human Genetics, 1-8. https://doi.org/10.1017/thg.2026.10109
Vancouver
Loughman L, Goh S, Woodward KJ, Ricciardi JL, Wise C, Poulton C, et al. Reduced Diagnostic Yield of Whole Exome Sequencing in Patients With Chromosomal Microarray Detected Copy Number Variants of Uncertain Significance. Twin Research and Human Genetics. 2026:1-8. doi:10.1017/thg.2026.10109
BibTeX
@article{Loughman2026,
author = {Loughman, Lily and Goh, Shuxiang and Woodward, Karen J and Ricciardi, Jamie-Lee and Wise, Cheryl and Poulton, Cathryn and Townshend, Sharron and Pathak, Gargi and McKenzie, Fiona and McGinnis, Kaitlin and Slee, Jennie and Kiraly-Borri, Cathy and Kamien, Benjamin},
title = {Reduced Diagnostic Yield of Whole Exome Sequencing in Patients With Chromosomal Microarray Detected Copy Number Variants of Uncertain Significance},
journal = {Twin Research and Human Genetics},
year = {2026},
pages = {1--8},
doi = {10.1017/thg.2026.10109}
}
EUVIMED